{"name": "Carolus Therapeutics",
 "permalink": "carolus-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/carolus-therapeutics",
 "homepage_url": "http://www.carolustherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@carolustherapeutics.com",
 "phone_number": "(858) 750-4731",
 "description": "",
 "created_at": "Wed Mar 06 01:42:26 UTC 2013",
 "updated_at": "Wed Mar 06 13:13:00 UTC 2013",
 "overview": "\u003Cp\u003ECarolus Therapeutics, Inc. is a biopharmaceutical company committed to the development of innovative new drugs that will provide relief to patients suffering from a host of disorders triggered by acute and chronic inflammation. The clinical and commercialization focus of the company is on novel therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines and prevent or reverse inflammation associated with a broad array of human diseases. The company\u2019s patented technology represents a promising advance in inflammation therapy where the underlying disease, as opposed to the symptoms, is treated without significant side effect profiles.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0024/0118/240118v1-max-150x150.jpg"],
     [[179,
       54],
      "assets/images/resized/0024/0118/240118v1-max-250x250.jpg"],
     [[179,
       54],
      "assets/images/resized/0024/0118/240118v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President, CEO and Director",
    "person":
     {"first_name": "Court",
      "last_name": "R. Turner",
      "permalink": "court-r-turner",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Douglas",
      "last_name": "J. Downs",
      "permalink": "douglas-j-downs-2",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.25M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.finsmes.com/2013/03/carolus-therapeutics-receives-2-25m-debt-facility-square-1-bank.html",
    "source_description": "Carolus Therapeutics Receives $2.25M Debt Facility from Square 1 Bank",
    "raised_amount": 2250000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Square 1 Bank",
         "permalink": "square-1-bank",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0001/4526/14526v5-max-150x150.png"],
             [[225,
               60],
              "assets/images/resized/0001/4526/14526v5-max-250x250.png"],
             [[225,
               60],
              "assets/images/resized/0001/4526/14526v5-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "11099 North Torrey Pines Road",
    "address2": "Suite 290",
    "zip_code": "92037",
    "city": "La Jolla",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}